BR112016028653A2 - métodos de tratamento de doenças e distúrbios neurodesenvolvimentais - Google Patents
métodos de tratamento de doenças e distúrbios neurodesenvolvimentaisInfo
- Publication number
- BR112016028653A2 BR112016028653A2 BR112016028653A BR112016028653A BR112016028653A2 BR 112016028653 A2 BR112016028653 A2 BR 112016028653A2 BR 112016028653 A BR112016028653 A BR 112016028653A BR 112016028653 A BR112016028653 A BR 112016028653A BR 112016028653 A2 BR112016028653 A2 BR 112016028653A2
- Authority
- BR
- Brazil
- Prior art keywords
- disorders
- methods
- neurodevelopmental diseases
- treating neurodevelopmental
- treating
- Prior art date
Links
- 208000029726 Neurodevelopmental disease Diseases 0.000 title 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Insects & Arthropods (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2014902173A AU2014902173A0 (en) | 2014-06-06 | Methods of treating neurodevelopmental diseases and disorders | |
| PCT/AU2015/050310 WO2015184509A1 (en) | 2014-06-06 | 2015-06-05 | Methods of treating neurodevelopmental diseases and disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112016028653A2 true BR112016028653A2 (pt) | 2018-07-10 |
Family
ID=54765877
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112016028653A BR112016028653A2 (pt) | 2014-06-06 | 2015-06-05 | métodos de tratamento de doenças e distúrbios neurodesenvolvimentais |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US9925163B2 (enExample) |
| EP (1) | EP3151824B1 (enExample) |
| JP (2) | JP6598262B2 (enExample) |
| KR (1) | KR102496390B1 (enExample) |
| CN (1) | CN106659704B (enExample) |
| AU (3) | AU2015271652B2 (enExample) |
| BR (1) | BR112016028653A2 (enExample) |
| CA (1) | CA2951288C (enExample) |
| ES (1) | ES3014042T3 (enExample) |
| MX (1) | MX377588B (enExample) |
| NZ (1) | NZ727412A (enExample) |
| WO (1) | WO2015184509A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3151824B1 (en) | 2014-06-06 | 2025-03-05 | Meizon Innovation 2 Pty Ltd | Trans-10-hydroxy-2-decenoic acid for use in the treatment of autism spectrum disorder |
| US11197840B2 (en) * | 2015-12-04 | 2021-12-14 | Wah Chin BOON | Methods of treating or alleviating mental disorders and associated symptoms |
| CN116570582A (zh) * | 2023-05-19 | 2023-08-11 | 中国药科大学 | 10-羟基癸烯酸在制备重度抑郁治疗药物中的应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1025185A (en) | 1911-03-23 | 1912-05-07 | William J Gruss | Regrinder. |
| JPH0967252A (ja) | 1995-09-05 | 1997-03-11 | Zenkoku Royal Jelly Kosei Torihiki Kiyougikai | ローヤルゼリーに含まれるトランス−１０−ヒドロキシ−デセン酸を有効成分とするアンジオテンシン転換酵素阻害剤及びインスリン様作用剤 |
| WO2007130581A2 (en) | 2006-05-04 | 2007-11-15 | Hardwicke Susan B | Compositions and methods for psychiatric conditions and cognition enhancement |
| US20100204498A1 (en) | 2007-09-19 | 2010-08-12 | Munekazu Iinuma | Agent having neurotrophic factor-like activity |
| WO2009154197A1 (ja) | 2008-06-17 | 2009-12-23 | ジャパンローヤルゼリー株式会社 | 認知障害改善剤 |
| BR112013018898B1 (pt) * | 2011-01-27 | 2021-10-05 | Neuren Pharmaceuticals Limited | Uso de ácido glicil-l-2-metilprolil-l-glutâmico e análogos do mesmo para o tratamento de transtornos do espectro do autismo |
| US10052319B2 (en) * | 2012-04-26 | 2018-08-21 | Sumitomo Dainippon Pharma Co., Ltd. | Medicament for treating mental and behavioural disorders |
| TWI636975B (zh) | 2012-04-27 | 2018-10-01 | 日本臟器製藥股份有限公司 | 反式－２－癸烯酸衍生物及含該衍生物之藥劑 |
| CN103816307B (zh) | 2014-03-12 | 2016-09-14 | 张国显 | 神经生长再造丸及其制备方法 |
| EP3151824B1 (en) | 2014-06-06 | 2025-03-05 | Meizon Innovation 2 Pty Ltd | Trans-10-hydroxy-2-decenoic acid for use in the treatment of autism spectrum disorder |
| US11197840B2 (en) | 2015-12-04 | 2021-12-14 | Wah Chin BOON | Methods of treating or alleviating mental disorders and associated symptoms |
-
2015
- 2015-06-05 EP EP15803574.1A patent/EP3151824B1/en active Active
- 2015-06-05 BR BR112016028653A patent/BR112016028653A2/pt not_active Application Discontinuation
- 2015-06-05 NZ NZ727412A patent/NZ727412A/en unknown
- 2015-06-05 CN CN201580041707.XA patent/CN106659704B/zh active Active
- 2015-06-05 MX MX2016016118A patent/MX377588B/es active IP Right Grant
- 2015-06-05 JP JP2017516008A patent/JP6598262B2/ja active Active
- 2015-06-05 US US15/316,110 patent/US9925163B2/en active Active
- 2015-06-05 AU AU2015271652A patent/AU2015271652B2/en active Active
- 2015-06-05 WO PCT/AU2015/050310 patent/WO2015184509A1/en not_active Ceased
- 2015-06-05 KR KR1020177000415A patent/KR102496390B1/ko active Active
- 2015-06-05 ES ES15803574T patent/ES3014042T3/es active Active
- 2015-06-05 CA CA2951288A patent/CA2951288C/en active Active
-
2018
- 2018-02-08 US US15/892,144 patent/US10251856B2/en active Active
-
2019
- 2019-02-22 US US16/282,880 patent/US10933043B2/en active Active
- 2019-09-25 JP JP2019174687A patent/JP6994613B2/ja active Active
-
2021
- 2021-08-27 AU AU2021221914A patent/AU2021221914A1/en not_active Abandoned
-
2025
- 2025-01-03 AU AU2025200041A patent/AU2025200041A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ES3014042T3 (en) | 2025-04-16 |
| MX2016016118A (es) | 2017-07-26 |
| JP6994613B2 (ja) | 2022-01-14 |
| KR20170026457A (ko) | 2017-03-08 |
| AU2015271652A1 (en) | 2017-01-05 |
| US9925163B2 (en) | 2018-03-27 |
| JP6598262B2 (ja) | 2019-10-30 |
| AU2025200041A1 (en) | 2025-01-23 |
| US20180214405A1 (en) | 2018-08-02 |
| NZ727412A (en) | 2023-07-28 |
| AU2015271652B2 (en) | 2021-05-27 |
| EP3151824C0 (en) | 2025-03-05 |
| JP2019214623A (ja) | 2019-12-19 |
| US10933043B2 (en) | 2021-03-02 |
| US20170087110A1 (en) | 2017-03-30 |
| JP2017517574A (ja) | 2017-06-29 |
| KR102496390B1 (ko) | 2023-02-03 |
| MX377588B (es) | 2025-03-10 |
| EP3151824A1 (en) | 2017-04-12 |
| CN106659704B (zh) | 2020-03-10 |
| CN106659704A (zh) | 2017-05-10 |
| CA2951288A1 (en) | 2015-12-10 |
| CA2951288C (en) | 2024-01-02 |
| US20190314315A1 (en) | 2019-10-17 |
| AU2021221914A1 (en) | 2021-09-23 |
| WO2015184509A1 (en) | 2015-12-10 |
| US10251856B2 (en) | 2019-04-09 |
| EP3151824B1 (en) | 2025-03-05 |
| EP3151824A4 (en) | 2017-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL285151B1 (en) | Methods for the treatment of fgf21-related disorders | |
| IL290994A (en) | Methods of diagnosing and treating conduct disorder | |
| IL253244B1 (en) | Methods for treating retinal diseases | |
| ZA201807084B (en) | Methods of treatment of cholestatic diseases | |
| IL249292A0 (en) | Methods and devices for treating pulmonary edema | |
| EP4212536C0 (en) | BENZOXAZEPINE OXAZOLIDINONE COMPOUNDS AND METHODS OF USE | |
| DK3212233T3 (da) | Kombinationsterapi til behandling af sygdom | |
| LT3212189T (lt) | Pakeisti chromanai ir naudojimo būdas | |
| ZA201702214B (en) | Methods of using interleukin-10 for treating diseases and disorders | |
| HUE059303T2 (hu) | Acetilkolin-észteráz-gátlók bõrbetegségek kezelésére | |
| IL262852A (en) | Treatment of complement-mediated disorders | |
| IL257764B (en) | Methods for treatment of diseases | |
| PL3393468T3 (pl) | Metody leczenia niedoboru odporności | |
| LT3119384T (lt) | Intrahepatinių cholestazinių ligų gydymas | |
| DK3848028T3 (da) | Fremgangsmåder til behandling af øjenlidelser | |
| GB201607388D0 (en) | Treatment of impulsivity-related disorders | |
| IL253847A0 (en) | Methods of treating diseases | |
| IL259381B (en) | Mirabegron for the treatment of retinal diseases | |
| BR112016028653A2 (pt) | métodos de tratamento de doenças e distúrbios neurodesenvolvimentais | |
| IL252779A0 (en) | Prevention and treatment of inflammatory conditions | |
| LT3302499T (lt) | Mitochondrinių ligų gydymas | |
| PL3131549T3 (pl) | Sposób leczenia zaburzeń ruchowych przy użyciu befiradolu | |
| HUE063820T2 (hu) | Módszerek kardiovaszkuláris betegségek kezelésére | |
| DK3182980T3 (da) | Behandling af glykosyleringsmangelsygdomme | |
| IL252707A0 (en) | Compositions and methods for treating diseases and conditions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |